CMBA
AGN

C.M. Bidwell & Associates’s Allergan plc AGN Stock Holding History

C.M. Bidwell & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,645
Closed -$885K – 487
2018
Q3 		$885K Buy
+4,645
New +$853K 0.84% 27
2016
Q4 		– Sell
-2,395
Closed -$552K – 333
2016
Q3 		$552K Buy
+2,395
New +$585K 0.13% 95
2014
Q2 		– Sell
-19,290
Closed -$3.97M – 305
2014
Q1 		$3.97M Sell
19,290
-275
-1% -$54.5K 0.95% 48
2013
Q4 		$3.29M Sell
19,565
-7,700
-28% -$1.2M 0.81% 62
2013
Q3 		$3.93M Buy
27,265
+35
+0.1% +$4.66K 1.08% 23
2013
Q2 		$3.44M Buy
+27,230
New +$3.08M 1.01% 41

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

C.M. Bidwell & Associates's AGN Position: Q4 2018 in Review

C.M. Bidwell & Associates sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 4,645 shares — an estimated $885K sold.

C.M. Bidwell & Associates first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $3.97M in Q1 2014. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • C.M. Bidwell & Associates reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 4,645 Allergan plc shares in Q4 2018, an estimated $885K.
  • C.M. Bidwell & Associates first reported a position in Allergan plc in Q2 2013 and held it in 6 quarters.
  • C.M. Bidwell & Associates's Allergan plc position peaked at $3.97M in Q1 2014.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.